NIH Funding Opportunity: Clinical Coordinating Center for Multi-Site Trials
Summary
The National Institutes of Health (NIH) has issued a Notice of Funding Opportunity (NOFO) for a Clinical Coordinating Center (CCC) to support investigator-initiated multi-site clinical trials. This opportunity encourages innovative trial designs and requires applications to be relevant to the NHLBI mission.
What changed
The National Institutes of Health (NIH), specifically the National Heart, Lung, and Blood Institute (NHLBI), has released a Notice of Funding Opportunity (NOFO) for the establishment of a Clinical Coordinating Center (CCC) to manage multi-site clinical trials. This NOFO supports investigator-initiated trials, including efficacy, comparative effectiveness, pragmatic, and dissemination/implementation science trials, encouraging innovative designs like platform and adaptive trials. Applications must align with the NHLBI's research mission and the NIH's definition of a clinical trial, and will utilize a bi-phasic, milestone-driven cooperative agreement mechanism.
Eligible entities include educational institutions, government agencies, non-profits, and for-profit businesses, including foreign organizations. Applicants must submit a comprehensive scientific and operational plan covering project management, recruitment, retention, scientific conduct, and dissemination. A companion NOFO exists for a Data Coordinating Center (DCC), and both CCC and DCC applications must be submitted by the same deadline. Applicants are strongly encouraged to contact the Scientific/Research contact prior to submission. The objective is to develop and conduct trials that address health outcome gaps within the US population and promote health equity.
What to do next
- Review NOFO for eligibility and application requirements
- Contact Scientific/Research contact prior to submission
- Submit CCC application and companion DCC application by the specified deadline
Source document (simplified)
Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)
Agency: National Institutes of Health
Assistance Listings: 93.837 -- Cardiovascular Diseases Research
93.838 -- Lung Diseases Research
93.839 -- Blood Diseases and Resources Research
93.233 -- National Center on Sleep Disorders Research
93.840 -- Translation and Implementation Science Research for Heart, Lung, Blood Diseases, and Sleep Disorders
Last Updated: March 18, 2026 View version history on Grants.gov
Description
This Notice of Funding Opportunity (NOFO) supports applications to develop and conduct a Clinical Coordinating Center (CCC) for investigator-initiated multi-site clinical trials including efficacy, comparative effectiveness, pragmatic and/or dissemination and implementation science clinical trials. Trials using innovative designs such as platform trials, adaptive, and Bayesian designs are encouraged. These trials may include ones that test different therapeutic, behavioral, dissemination and implementation science clinical trials and/or prevention strategies.Trials for which this NOFO applies must... be relevant to the research mission of the NHLBI and meet the NIH definition of a clinical trial (see NOT-OD-15-015). For additional information about the mission, strategic vision, and research priorities of the NHLBI, applicants are encouraged to consult the NHLBI website.This NOFO will utilize a bi-phasic, milestone-driven cooperative agreement mechanism of award and runs in parallel with a companion NOFO for a collaborating Data Coordinating Center (PAR-27-013). The objective of the CCC application is to present the scientific rationale for the clinical trial and a comprehensive scientific and operational plan that describes it. The application should address project management, subject recruitment and retention, performance milestones, scientific conduct of the trial, and dissemination of results. The application should also describe its approaches to increasing community engagement from conceptual design of the intervention through implementation and sustainability and close gaps in health outcomes within the US population and increase health for all.Both a CCC application and a collaborating Data Coordinating Center (DCC) application must be submitted on the same application due date for consideration by NHLBI. Applicants are strongly encouraged to contact the appropriate Scientific/Research contact prior to submitting an application. Show full description
Eligibility
Eligible applicants
Education
- Public and state institutions of higher education
- Independent school districts
- Private institutions of higher education
Government
- State governments
- City or township governments
- Special district governments
- Public and Indian housing authorities
- County governments
- Federally recognized Native American tribal governments
Nonprofit
- Nonprofits non-higher education with 501(c)(3)
- Other Native American tribal organizations
- Nonprofits non-higher education without 501(c)(3)
Business
- Small businesses
- For-profit organizations other than small businesses
Miscellaneous
- Other
Additional information
Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International CollaborationsNon-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.NIH will no longer issue awards (i.e., new, renewal, or non-competing continuation) to domestic or foreign entities that involve foreign subawards/subcontracts. All NIH-funded research involving foreign subawards/subcontracts must be submitted in response to a NOFO that is specifically designated for funded international collaborations. This new requirement was effective, May 1, 2025.Applications involving foreign subawards/subcontracts submitted in response to this NOFO will be deemed noncompliant and will not be considered for funding. This policy applies to all monetary international collaborations resulting in foreign subawards/subcontracts, however, it does not preclude unfunded international collaborations or foreign components, funding for foreign consultants, or procurement of unique equipment or supplies from foreign vendors.
Grantor contact information
Description
Division of Cardiovascular Sciences
NHLBIDCVSClinical@mail.nih.gov
NHLBIDCVSClinical@mail.nih.gov
NHLBIDCVSClinical@mail.nih.gov
Documents
Download all
| File name | Description | Last updated |
| --- | --- | --- |
| PAR-27-012-Full-Announcement.html | PAR-27-012-Full-Announcement.html | Mar 18, 2026 12:46 PM UTC |
Link to additional information
--
Closing: November 2, 2028
Application process
This site is a work in progress. Go to www.grants.gov to apply, track application status, and subscribe to updates. View on Grants.gov
Award
$--
Program Funding
--
Expected awards
$--
Award Minimum
$--
Award Maximum
Funding opportunity number:
PAR-27-012
Cost sharing or matching requirement:
No Funding instrument type:
Cooperative agreement
Opportunity Category:
Discretionary
Opportunity Category Explanation:
-- Category of Funding Activity:
Health
Category Explanation:
--
History
Version:
1
Posted date:
March 18, 2026
Archive date:
January 2, 2029
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Trade & Sanctions alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when Grants.gov Open Opportunities publishes new changes.